Abstract
On May 26, 2020, the FDA approved nivolumab with ipili-mumab and two cycles of platinum-doublet chemotherapy as first-line treatment for patients with......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
